- Home
- VCEL vs AAMI Comparison
VCEL vs AAMI Comparison
Compare VCEL & AAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- AAMI
- Stock Information
- Founded
- VCEL 1989
- AAMI 1980
- Country
- VCEL United States
- AAMI United States
- Employees
- VCEL N/A
- AAMI N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- AAMI Investment Managers
- Sector
- VCEL Health Care
- AAMI Finance
- Exchange
- VCEL Nasdaq
- AAMI Nasdaq
- Market Cap
- VCEL 1.6B
- AAMI 1.6B
- IPO Year
- VCEL 1997
- AAMI N/A
- Fundamental
- Price
- VCEL $33.59
- AAMI $47.54
- Analyst Decision
- VCEL Strong Buy
- AAMI Hold
- Analyst Count
- VCEL 6
- AAMI 3
- Target Price
- VCEL $58.60
- AAMI $39.67
- AVG Volume (30 Days)
- VCEL 703.6K
- AAMI 268.9K
- Earning Date
- VCEL 11-06-2025
- AAMI 10-30-2025
- Dividend Yield
- VCEL N/A
- AAMI 0.08%
- EPS Growth
- VCEL 2045.40
- AAMI 43.58
- EPS
- VCEL 0.13
- AAMI 2.41
- Revenue
- VCEL $249,119,000.00
- AAMI $538,200,000.00
- Revenue This Year
- VCEL $18.35
- AAMI $21.37
- Revenue Next Year
- VCEL $22.26
- AAMI $16.37
- P/E Ratio
- VCEL $259.38
- AAMI $20.02
- Revenue Growth
- VCEL 16.13
- AAMI 18.76
- 52 Week Low
- VCEL $29.24
- AAMI $22.60
- 52 Week High
- VCEL $63.00
- AAMI $51.65
- Technical
- Relative Strength Index (RSI)
- VCEL 52.73
- AAMI 55.16
- Support Level
- VCEL $31.34
- AAMI $43.75
- Resistance Level
- VCEL $35.70
- AAMI $47.45
- Average True Range (ATR)
- VCEL 1.48
- AAMI 1.49
- MACD
- VCEL 0.46
- AAMI -0.02
- Stochastic Oscillator
- VCEL 71.12
- AAMI 67.06
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About AAMI Acadian Asset Management Inc. Common Stock
Acadian Asset Management Inc is a holding company that operates a systematic investment management business through its subsidiary, that offers institutional investors across the globe access to a diversified array of systematic investment strategies designed to meet a range of risk and return objectives.